pantethine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
3417 16816-67-4

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • pantethine
  • lipodel
  • pantetina
  • panthecin
  • pantomin
  • pantosin
  • Molecular weight: 554.72
  • Formula: C22H42N4O8S2
  • CLOGP: -1.44
  • LIPINSKI: 3
  • HAC: 12
  • HDO: 8
  • TPSA: 197.32
  • ALOGS: -3.67
  • ROTB: 19

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
kinase-safety-class ACVR2A,ACVR2B,ACVRL1,AKT2,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK4,CDK5,CDK9,DDR1,DYRK1B,EGFR,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,GSK3B,ITK,JAK1,JAK2,JAK3,MAP2K6,MAP3K21,MAP3K7,MAPK10,MAPK7,MAPK8,MAPK9,MAPKAPK2,MTOR,NTRK2,PDK1,PDK2,PDK4,PDPK1,PIK3CB,PIM2,PLK1,PLK2,PLK3,PLK4,PRKCD,PRKDC,SIK2,SIK3,STK33,SYK,TEK,TGFBR1,TTK,ULK1,ZAP70 57
kinase-selectivity-class ACVRL1,AXL,BMX,BRAF,CDK16,CDK6,CDK9,CHUK,DYRK1A,GRK2,IRAK3,MAP2K6,PDK1,PDK2,PIK3CD,TEK 16
pfas-class PFAS structural alert (1 = True, 0 = False) 0

Approvals:

DateAgencyCompanyOrphan
None FDA

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Platelet count decreased 54.57 39.95 26 800 136943 90490678

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Pneumonia 40.46 31.97 43 714 422106 42198472

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Platelet count decreased 70.01 31.56 45 1800 230398 110357056
Hepatic function abnormal 55.82 31.56 28 1817 89267 110498187
Interstitial lung disease 46.71 31.56 29 1816 139305 110448149
Ileus 46.65 31.56 18 1827 30711 110556743
Pneumonia 42.79 31.56 62 1783 876652 109710802
Neutrophil count decreased 42.63 31.56 26 1819 120915 110466539
Pneumonia aspiration 38.01 31.56 21 1824 81212 110506242
Decreased appetite 36.23 31.56 42 1803 475804 110111650
Pyrexia 33.27 31.56 56 1789 898209 109689245
Salivary hypersecretion 32.98 31.56 12 1833 17409 110570045

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC A11HA32 ALIMENTARY TRACT AND METABOLISM
VITAMINS
OTHER PLAIN VITAMIN PREPARATIONS
Other plain vitamin preparations
CHEBI has role CHEBI:23354 coenzyme
CHEBI has role CHEBI:50733 nutraceutical

Related Drugs by ATC class:

A11HA Other plain vitamin preparations 10 drugs

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 12.1 acidic
pKa2 12.7 acidic
pKa3 13.1 acidic
pKa4 13.7 acidic
pKa5 13.9 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D01234 KEGG_DRUG
C0070034 UMLSCUI
CHEMBL2104786 ChEMBL_ID
DB11190 DRUGBANK_ID
C005425 MESH_SUPPLEMENTAL_RECORD_UI
7K81IL792L UNII
452306 PUBCHEM_CID
32863 RXNORM
006957 NDDF
CHEBI:31959 CHEBI

Pharmaceutical products:

None